Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''Listing Regulations''), we hereby inform you ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indokem Ltd's Board (meeting held Nov 13, 2025) approved the unaudited standalone and consolidated financial results for Q2 and H1 FY26 (ended Sept 30, 2025), along with a revised Related Party Transactions Policy and a voluntarily adopted Dividend Distribution Policy. On a standalone basis, Q2 FY26 revenue from operations was Rs 3,491 lakhs (vs Rs 3,640 lakhs in Q2 FY25), while H1 FY26 revenue rose ~4% to Rs 7,123 lakhs. The company swung back to profitability with H1 standalone PAT of Rs 99 lakhs (against a loss of Rs 252 lakhs in H1 FY25) and consolidated PAT of Rs 111 lakhs (against a loss of Rs 140 lakhs). Statutory auditors CNK & Associates LLP issued an unqualified limited review report on both sets of results. Standalone operating cash flow was Rs 179 lakhs, though overall cash balance dipped marginally to Rs 26 lakhs.
A clear return to profitability at both standalone and consolidated levels after a loss-making H1 last year is a positive signal for shareholders, though revenue growth remains modest and the auditor reviewed one subsidiary and noted two others had unreviewed financials (deemed not material). The voluntary adoption of governance policies signals improved transparency, which may be viewed favorably by investors.